Inter-individual differences in the metabolism of environmental toxicants: cytochrome P450 1A2 as a prototype.

[1]  F. Guengerich,et al.  Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties. , 1999, Biochemistry.

[2]  F. Guengerich,et al.  Comparative metabolism of 1-, 2-, and 4-nitropyrene by human hepatic and pulmonary microsomes. , 1999, Cancer research.

[3]  G. Walker.  Skiing the black diamond slope: progress on the biochemistry of translesion DNA synthesis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  F. Guengerich,et al.  Effects of motorcycle exhaust on cytochrome P-450-dependent monooxygenases and glutathione S-transferase in rat tissues. , 1998, Journal of toxicology and environmental health. Part A.

[5]  F. Guengerich,et al.  Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2. , 1998, Chemical research in toxicology.

[6]  N. Vermeulen,et al.  Expression of human cytochrome P450 1A2 in Escherichia coli: a system for biotransformation and genotoxicity studies of chemical carcinogens. , 1998, Mutagenesis.

[7]  H. Iwata,et al.  Establishment of a Salmonella tester strain highly sensitive to mutagenic heterocyclic amines. , 1998, Cancer research.

[8]  F. Guengerich,et al.  Metabolic activation of aromatic amine mutagens by simultaneous expression of human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and N-acetyltransferase in Escherichia coli. , 1998, Chemical research in toxicology.

[9]  F. Guengerich,et al.  Drug metabolism by Escherichia coli expressing human cytochromes P450 , 1997, Nature Biotechnology.

[10]  Ferran Sanz,et al.  Three-dimensional modelling of human cytochrome P450 1A2 and its interaction with caffeine and MeIQ , 1997, J. Comput. Aided Mol. Des..

[11]  H. Yamazaki,et al.  Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase. , 1996, Archives of biochemistry and biophysics.

[12]  J. Essigmann,et al.  Mutational properties of the primary aflatoxin B1-DNA adduct. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[13]  F. Guengerich,et al.  New applications of bacterial systems to problems in toxicology. , 1996, Critical reviews in toxicology.

[14]  H. Barnes.  Maximizing expression of eukaryotic cytochrome P450s in Escherichia coli. , 1996, Methods in enzymology.

[15]  F. Guengerich,et al.  Bioactivation of aromatic amines by recombinant human cytochrome P4501A2 expressed in Ames tester strain bacteria: a substitute for activation by mammalian tissue preparations. , 1995, Cancer research.

[16]  M A Butler,et al.  Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  M. Waterman,et al.  Flavodoxin and NADPH-flavodoxin reductase from Escherichia coli support bovine cytochrome P450c17 hydroxylase activities. , 1994, The Journal of biological chemistry.

[18]  H. Yamazaki,et al.  Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes. , 1994, Molecular pharmacology.

[19]  R. Tukey,et al.  Expression of modified human cytochrome P450 1A2 in Escherichia coli: stabilization, purification, spectral characterization, and catalytic activities of the enzyme. , 1994, Archives of biochemistry and biophysics.

[20]  T. Sugimura,et al.  Heterocyclic amines in cooked foods: candidates for causation of common cancers. , 1994, Journal of the National Cancer Institute.

[21]  F. Guengerich,et al.  Roles of human hepatic and pulmonary cytochrome P450 enzymes in the metabolism of the environmental carcinogen 6-nitrochrysene. , 1993, Cancer research.

[22]  M A Butler,et al.  Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. , 1992, Environmental health perspectives.

[23]  K. El-Bayoumy.  Environmental carcinogens that may be involved in human breast cancer etiology. , 1992, Chemical research in toxicology.

[24]  R. Hayes,et al.  Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. , 1992, Pharmacogenetics.

[25]  O. Gotoh,et al.  Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. , 1992, The Journal of biological chemistry.

[26]  F. Guengerich,et al.  Human cytochrome P-450 enzymes. , 1992, Life sciences.

[27]  T. Shimada,et al.  Activation of Amino-α-carboline, 2-Amino-1-methyl-6-phenylimidazo[4,5- b ]pyridine, and a Copper Phthalocyanine Cellulose Extract of Cigarette Smoke Condensate by Cytochrome P-450 Enzymes in Rat and Human Liver Microsomes , 1991 .

[28]  J. Miller,et al.  A set of lacZ mutations in Escherichia coli that allow rapid detection of specific frameshift mutations. , 1990, Genetics.

[29]  R. Tukey,et al.  Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450. , 1990, Cancer research.

[30]  T. Shimada,et al.  Inactivation of 1,3-, 1,6-, and 1,8-dinitropyrene by cytochrome P-450 enzymes in human and rat liver microsomes. , 1990, Cancer research.

[31]  M. Ingelman-Sundberg,et al.  Differential rates of metabolic activation and detoxication of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by different cytochrome P450 enzymes. , 1990, Carcinogenesis.

[32]  M. Butler,et al.  Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[33]  T. Shimada,et al.  Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002. , 1989, Cancer research.

[34]  F. Gonzalez,et al.  Human cDNA‐Expressed Cytochrome P450 IA2: Mutagen Activation and Substrate Specificity , 1989, Molecular carcinogenesis.

[35]  D W Nebert,et al.  The P450 gene superfamily: recommended nomenclature. , 1987, DNA.

[36]  F. Guengerich,et al.  Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism. , 1985, The Journal of biological chemistry.

[37]  T. Fujita,et al.  PCBs: structure–function relationships and mechanism of action , 1985, Environmental health perspectives.

[38]  F. Guengerich,et al.  Regulation of cytochrome P-450. Immunochemical quantitation of eight isozymes in liver microsomes of rats treated with polybrominated biphenyl congeners. , 1983, The Journal of biological chemistry.

[39]  F. Guengerich,et al.  Purification and characterization of liver microsomal cytochromes p-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or beta-naphthoflavone. , 1982, Biochemistry.

[40]  S. Safe,et al.  Halogenated biphenyls as AHH inducers: effects of different halogen substituents. , 1982, Life sciences.

[41]  M. Brodie,et al.  Biphasic O-deethylation of phenacetin and 7-ethoxycoumarin by human and rat liver microsomal fractions. , 1981, Biochemical pharmacology.

[42]  A. Conney,et al.  Effect of cigarette smoking on phenacetin metabolism , 1974, Clinical pharmacology and therapeutics.